Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
chorea
MeSH D002819 - chorea
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020820:
Dyskinesias
54 Companies
12 Drugs
$
Success rate
D002819:
Chorea
1 Company
1 Drug
$
Success rate
D006816:
Huntington disease
47 Companies
5 Drugs
$
Success rate
D020150:
Chorea gravidarum
0 Companies
0 Drugs
Success rate
D054546:
Neuroacanthocytosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Teva
Deutetrabenazine
Austedo
2031-04-03
2017-04-03
$1,225 M
Y2023
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
17
%
1/6
Phase 3
0
%
0/1
Approved:
0
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Deutetrabenazine
,
Dutetrabenazine
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use